Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

13.84
Delayed Data
As of Nov 17
 +1.05 / +8.21%
Today’s Change
10.85
Today|||52-Week Range
39.41
-61.82%
Year-to-Date
Arthur Zaske & Associates, LLC Buys Vanguard Energy, Teva Pharmaceutical Industries, ...
Nov 16 / GuruFocus News - Paid Partner Content
BioDelivery (BDSI) Q3 Earnings, Sales Beat Estimates
Nov 10 / Zacks.com - Paid Partner Content
Hampstead Capital LLP Buys Merck Inc, American International Group Inc, Pioneer Natur...
Nov 16 / GuruFocus News - Paid Partner Content
VIVUS (VVUS) Q3 Loss Narrows, Qsymia Falters, Shares Down
Nov 09 / Zacks.com - Paid Partner Content
AstraZeneca's (AZN) Asthma Drug Benralizumab Approved by FDA
Nov 15 / Zacks.com - Paid Partner Content
Mylan (MYL) Misses on Earnings and Sales Estimates in Q3
Nov 06 / Zacks.com - Paid Partner Content
Orexigen (OREX) Q3 Loss Narrower Than Expected, Stock Up
Nov 14 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Pfizer, Teva's Q3 Earnings, Novartis Seeks New Indication for K...
Nov 06 / Zacks.com - Paid Partner Content
Recommended Reading: Teva
Nov 13 / TheStreet.com - Paid Partner Content